MarketingMedicalPolicy,Access,Value, andEvidenceConsultingData,Technology,and Media
murmuration of birds

thought leadership

Achieving equitable access to healthcare innovation in the complex Southeast Asian Nations region


This update provides key takeaways from one of the expert sessions at the Zuellig Pharma Summit 2022, ‘Building a Healthier Asia: empowering more equitable access to healthcare innovation’. Zuellig Pharma and Knowledge Partner, Avalere Health, are pleased to share this summary from the post-summit report to contribute to raising awareness and progressing the conversation on enhancing access to healthcare in the Asia-Pacific region.

Achieving access to healthcare innovation for all in the Southeast Asian Nations region

During this session, expert speakers provided a deep dive into the Philippines, exploring what it means for the Association of Southeast Asian Nations (ASEAN) to achieve access to healthcare innovation for all, and learnings for other countries to address healthcare infrastructure challenges.


Rosario Vergeire, Officer-in-charge, Department of Health, Philippines

Rehan Q. Saghir, EVP, Zuellig Pharma Therapeutics

Key takeaways:
  • In the Philippines, there is a disparity in access to healthcare services for patients living in the geographically isolated and disadvantaged areas (GIDA) in the country. To provide quality healthcare services for all Filipinos, the Philippines has introduced rational reallocation of healthcare infrastructure and equipment aligned with the Philippine Health Facility Development Plan, where infrastructure requirements to build healthcare provider networks are calculated and the role of the private sector is included. To promote equity, a higher allocation of financing and human resources is assigned to underserved than to well‑served areas.
  • Additionally, under the Department of Health-Human Resources for Health Masterplan, investments in human resources are necessary to enable access to equitable primary care.
  • In most countries where government funding may be more limited by resource constraints, including the Philippines, there are opportunities for public partnerships with private payers, patient groups, and pharma companies, as well as other stakeholders, to make innovative treatments more accessible, and for addressing supply chain barriers that can reduce access due to cost, infrastructure, or even regulatory restrictions.
  • Some companies, especially smaller biotechnology firms from outside the region, may not have the capacity to reach markets and patients in Asia without partners. Similarly, smaller markets may need to be open to more creative approaches to becoming attractive destinations for companies to invest in patient access.
  • Equitable distribution of innovative treatments and access to them is critical to strengthen healthcare system resilience and requires the public sector and private sector to collaboratively leverage one another’s strengths to offer a unified response to crises or threats.


Read the full report to explore the barriers and solutions to equitable access in the Asia‑Pacific region

A full synopsis from the Zuellig Summit is available to download now. This report summarizes the key takeaways from all of the expert sessions:

  • Best care anywhere: Achieving access for all to healthcare innovation in a complex region
  • Partnering for health: Building strategic partnerships to achieve the goals for access and equity
  • Trust your doctor? Securing trust in the healthcare system: how does this help drive access and equity?
  • Health in your pocket: Leveraging digital solutions to empower community-centered and patient-centric care models
  • The last mile to healthcare: Reimagining strategic supply chains to ensure equitable supply across and within markets
  • Moving from “Wealth = Health” to “Health = Wealth”: Building value-based healthcare financing models that deliver equitable access
    Read the full synopsis of all the sessions


Supporting your Policy, Access, Value, and Evidence needs in the Asia-Pacific region

The Asia-Pacific region is characterized by its dynamic nature and rapidly evolving markets. These are critical to the future growth plans of our pharmaceutical and biotechnology clients, and we are leading many ground-breaking market access projects in the region.

Avalere Health, will help you bring out the best in your asset, using our extensive market access and disease area experience. Get in touch for a confidential conversation about your policy, access, value, and evidence needs.

How we use cookies

Cookies are files saved on your phone, tablet or computer when you visit a website.

We use cookies to store information about how you use the Fishawack Health website, such as the pages you visit.

For more information, check the cookie statement


Cookie settings

We use 4 types of cookies. You can choose which cookies you're happy for us to use.

Cookies that measure website use.

We use Google Analytics to measure how you use the website so we can improve it based on user needs. We do not allow Google to use or share the data about how you use this site.

  • how you got to the site
  • the pages you visit on, and how long you spend on each page
  • what you click on while you're visiting the site

Cookies that help with our communications and marketing

These cookies may be set by third party websites and do things like measure how you view Vimeo videos that are on

Cookies that remember your settings

These cookies do things like remember your preferences and the choices you make, to personalize your experience of using the site.

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (eg. Registering for new content alerts).

These cookies always need to be on.